| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/23/2007 | US20070196373 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 08/23/2007 | US20070196372 Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) |
| 08/23/2007 | US20070196371 Soluble il-17rcx4 and methods of using in inflammation |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196368 Method for Controlled Induction of Somatic Mutations and Use Thereof in Proteomics |
| 08/23/2007 | US20070196367 Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
| 08/23/2007 | US20070196366 Methods for treating cancer using an immunotoxin |
| 08/23/2007 | US20070196365 Immunoglobulin heavy chain variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/23/2007 | US20070196364 Pharmaceutical Formulation and Process |
| 08/23/2007 | US20070196363 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/23/2007 | US20070196362 Computational methods and systems to bolster an immune response |
| 08/23/2007 | US20070196360 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 08/23/2007 | US20070196346 Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer |
| 08/23/2007 | US20070196339 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/23/2007 | US20070196335 Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196330 Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes |
| 08/23/2007 | US20070196281 Method and articles for remote magnetically induced treatment of cancer and other diseases, and method for operating such article |
| 08/23/2007 | US20070196276 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 08/23/2007 | US20070196274 Immunoconjugates with improved efficacy for the treatment of diseases |
| 08/23/2007 | CA2822302A1 Methods of impairing osteoclast differentiation |
| 08/23/2007 | CA2652310A1 Human telomerase reverse transcriptase peptides |
| 08/23/2007 | CA2646623A1 Rna virus vaccines and methods |
| 08/23/2007 | CA2642828A1 Affinity regions |
| 08/23/2007 | CA2642606A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/23/2007 | CA2642577A1 Methods of manufacturing corticosteroid solutions |
| 08/23/2007 | CA2642473A1 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 08/23/2007 | CA2642270A1 Antibody formulation |
| 08/23/2007 | CA2642056A1 Hpv antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2642054A1 Influenza antigens, vaccine compositions, and related methods |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2638794A1 Functional antibodies |
| 08/23/2007 | CA2635430A1 Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| 08/23/2007 | CA2633005A1 Dengue chimeric viruses |
| 08/22/2007 | EP1820855A1 Anti-histone h1 monoclonal antibody and hybridoma capable of producing the same |
| 08/22/2007 | EP1820853A2 Recombinant influenza viruses for vaccines and gene therapy |
| 08/22/2007 | EP1820806A1 Affinity regions |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820513A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/22/2007 | EP1820512A1 Improved modified live brsv vaccine |
| 08/22/2007 | EP1820511A1 MHC binding peptides and their uses |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1819735A1 Ctla-4 antibody and aromatase inhibitor or combination treatment for breast cancer |
| 08/22/2007 | EP1819731A2 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer |
| 08/22/2007 | EP1819726A1 Modulation of ovulation |
| 08/22/2007 | EP1819722A1 Modulation of ovulation |
| 08/22/2007 | EP1819359A2 Anti-integrin immunoconjugates, methods and uses |
| 08/22/2007 | EP1819358A2 Antibodies against vascular endothelial growth factor receptor-1 |
| 08/22/2007 | EP1819357A2 Vaccines for the rapid response to pandemic avian influenza |
| 08/22/2007 | EP1819346A2 Oxytocin receptor antagonists and their use for the treatment of pulmonary related diseases |
| 08/22/2007 | EP1553979B1 Ihnv g fusion protein for immune stimulation |
| 08/22/2007 | EP1501542B1 Improved polysaccharide and glycoconjugate vaccines |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1326961B1 Compositions and methods for inducing specific cytolytic t cell responses |
| 08/22/2007 | EP1242446B1 Immunoenzymatic quantification method |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | EP1003531B1 Processes for preparing nucleic acid constructs |
| 08/22/2007 | EP0933423B1 Meltrins |
| 08/22/2007 | EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells |
| 08/22/2007 | CN1333077C Cascade expression of active fragment of cholecystokinin and application thereof |
| 08/22/2007 | CN1332714C Method for treating fibrosis by utilizing integrin alpha 4 subunit antagonist |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN1332712C Oncolytic virus therapy |
| 08/22/2007 | CN101023177A Non-integrative and non-replicative lentivirus, preparation and uses thereof |
| 08/22/2007 | CN101023172A Method of producing glycoprotein composition |
| 08/22/2007 | CN101023164A Cancerous disease modifying antibodies |
| 08/22/2007 | CN101023103A Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 08/22/2007 | CN101023101A Anti-rhesus D recombinant polyclonal antibody and methods of manufacture |
| 08/22/2007 | CN101023099A Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 08/22/2007 | CN101022831A Stabilizing formulations |
| 08/22/2007 | CN101022830A Ligands binding the complex of urokinase-type plasminogen activator(uPA) and its receptor(uPAR) that inhibit downstream upar interactions: identification and use in diagnosis or therapy |
| 08/22/2007 | CN101022829A Treatment of polychondritis or mononeuritis multiplex by using an antibody against CD20 |
| 08/22/2007 | CN101022828A Inhibition of factor b, the alternative complement pathway and methods related thereto |
| 08/22/2007 | CN101022827A Vaccine compositions and methods of treating coronavirus infection |
| 08/22/2007 | CN101022826A Bacterial compositions for the treatment of cancer |
| 08/22/2007 | CN101022825A Combination therapy for preventing or treating alzheimer's disease, and kit therefor |
| 08/22/2007 | CN101022824A Immunosuppressive exosomes |
| 08/22/2007 | CN101020894A Avirulent type-2 pig streptococcus strain and its prepn and application |
| 08/22/2007 | CN101020716A Prepn and application of human tumor relevant N-jointing glycosyl chain monoclonal antibody |
| 08/22/2007 | CN101020064A Brucellosis nucleic acid vaccine |
| 08/22/2007 | CN101020063A Vaccine for preventing and/or treating autoimmune disease |
| 08/22/2007 | CN101020055A SARS vaccine based on replicative vaccinia virus vector |
| 08/22/2007 | CN101020054A Inactivated vaccine for preventing and treating paramyxovirus disease of pigeon and its prepn |
| 08/22/2007 | CN101020053A Prepn process of inactivated rotavirus vaccine |
| 08/22/2007 | CN101020052A AIDS vaccine based on replicative vaccinia virus vector |
| 08/22/2007 | CN101020051A Prepn and usage of outer membrane protein subunit vaccine of seawater fish morbid vibrio |
| 08/22/2007 | CN101020050A Prepn and usage of extracellular product subunit vaccine of seawater fish morbid vibrio |
| 08/22/2007 | CN101019940A Organic composite Chinese medicine immunopotentiator/adjuvant and its prepn process |
| 08/22/2007 | CN101019845A Sodium myristyl aldehyde sulfate and its application as immunoadjuvant |
| 08/21/2007 | USRE39789 Tumor therapy |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259246 Hybridoma cell line producing monoclonal antibodies to bind to, to detect and qualitatively and quantitatively measure the presence of epitopes of prion proteins; neurodegenerative diseases of the central nervous system |
| 08/21/2007 | US7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the same |
| 08/21/2007 | US7259236 RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof |
| 08/21/2007 | US7259235 Method for generating an immune response and reagents therefor |
| 08/21/2007 | US7259232 Preferred segments of neural thread protein |
| 08/21/2007 | US7259151 AAV virions with decreased immunoreactivity and uses therefor |
| 08/21/2007 | US7259147 treating multiple sclerosisbby administering an inhibitor of JTT-1 antigen activity. |